Cambridge, MA
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
aavantibio.comThese are collections AavantiBio is a part of. Click on the collection name to view similar companies.
Series A
$107,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on AavantiBio.